Results 191 to 200 of about 8,326 (241)

Cyclic Vomiting Syndrome Versus Cannabinoid Hyperemesis Syndrome. [PDF]

J Neurogastroenterol Motil
Singh B, Grover P, Kaur G.
europepmc   +1 more source

PReCedeNT trial: Phase III randomized-controlled trial of Lutetium - 177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) plus Chemotherapy versus PRRT alone in FDG-avid, Well-differentiated Gastroenteropancreatic neuroendocrine tumors (GEP-NETs). [PDF]

BMC Cancer
Puranik AD, Dev ID, Yadav S, Rangarajan V, Agrawal A, Basu S, Chaudhari VA, Ramaswamy A, Ostwal V, Bhandare MS, Shrikhande SV, Parghane RV, Bhargava P, Bal MM, Yadav S, Patkar S, Goel M, Purandare NC, Shah S, Choudhury S, Ghosh S, Venkatachalam M.   +21 more
europepmc   +1 more source

Physiologically based pharmacokinetic modeling supports investigation of potential drug-drug interactions in the pre- and early post-hematopoietic stem cell transplantation stages. [PDF]

Front Pharmacol
Wang P, Lu J, Yang J.
europepmc   +1 more source

FGD3 mediates lytic cell death, enhancing efficacy and immunogenicity of chemotherapy agents in breast cancer. [PDF]

J Exp Clin Cancer Res
Zhu J, Dai X, Ghosh S, Wei E, Mao C, Jiang Q, Spaulding AJ, Mulligan MP, Romero R, Han YJ, Boudreau MW, Olopade O, Hergenrother PJ, Shapiro DJ.   +13 more
europepmc   +1 more source

Neural regulation of lung cancer: from mechanisms to clinical implications. [PDF]

Eur J Med Res
Xu L, Sun X, Yao Y, Fang H.
europepmc   +1 more source

Safety and antiemetic efficacy of weekly administration of netupitant/palonosetron plus dexamethasone during 5 weeks of concomitant chemo-radiotherapy-the DANGER-emesis study. [PDF]

Support Care Cancer
Detlefsen SS, Andersen DS, Knudsen AØ, Nøttrup TJ, Möller S, Nyvang GB, Jørgensen TL, Herrstedt J, Ruhlmann CH.   +8 more
europepmc   +1 more source

Olanzapine plus triple antiemetic therapy for prevention of carboplatin-induced nausea: a pooled analysis of two clinical trials. [PDF]

BMC Cancer
Kojima S, Inui N, Suzuki T, Tanaka K, Karayama M, Inoue Y, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nishimoto K, Matsuura S, Hashimoto D, Matsui T, Asada K, Suda T.   +17 more
europepmc   +1 more source

Impact of antiemetic prophylaxis on reducing trastuzumab deruxtecan dose modifications in HER2+/HER2-low breast cancer. [PDF]

Future Oncol
Shin J, Kim JY, Ahn HK, Ahn JS, Park YH.
europepmc   +1 more source

Substance P Augments Chemokine Production by Staphylococcus aureus Infected Murine Osteoclasts. [PDF]

Inflammation
Sipprell SE, Krueger QA, Mills EL, Marriott I, Johnson MB.   +4 more
europepmc   +1 more source

Impact of chain-length of sulfhydryl-modified surface-decorated surfactants on mucoadhesive nanostructured lipid carriers. [PDF]

Drug Deliv Transl Res
Kausar S, Duarte SOD, Hashmi AR, Zahra F, Erum A, Arshad S, Tulain UR, Asim MH, Fonte P.   +8 more
europepmc   +1 more source